Resolution Health Introduces Women's Health and Wellness Actio... (mentById('headline'); s.tl(this'o'getLin...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Resolution Health Introduces Women's Health and Wellness Action Campaign

Date:8/12/2008

mentById('headline'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >WLP) is the largest health benefits company in terms of medical membership in the United States. WellPoint is an independent licensee of the Blue Cross and Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Empire Blue Cross Blue Shield in 10 New York City metropolitan and surrounding counties and as Empire Blue Cross or Empire Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the city of Fairfax, the town of Vienna and the area east of State Route 123), Wisconsin; and through UniCare. Additional information about WellPoint is available at http://www.wellpoint.com.

About Eliza Corporation

Eliza Corporation is the leading provider of innovative, effective healthcare communications. Every day, our tailored interactions connect millions of people with timely, personally relevant information that drives healthier behavior. Each Eliza program is powered by our patented speech recognition technology, rich web and multi-media delivery platform, proven communications methodologies, and sophisticated data analytics. Our integrated communication strategies consistently yield the best outcomes in the industry in terms of improved engagement, health and wellness measures, and financial savings. Eliza's clients include the nation's leading health plans, disease management firms, pharmaceutical companies, pharmacy benefit managers, and employers. The results of our programs have been recognized by organizations including the Centers for Prevention and Disease Control, the BlueCross BlueShield Association, The Consumer Directed Health Care Congress, and Harvard Medical School
'/>"/>

SOURCE Resolution Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Stryker Announces Resolution Related to March 2005 U.S. Department of Justice Subpoena
2. RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM)
3. Wiley X Eyewear(R) Announces Successful Resolution of Patent Infringement Litigation Against PanOptx(R), Inc.
4. Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House
5. With Calorie Counting on Holiday Hiatus, NutriSystem Offers Advanced Resolution for 2008
6. AMA: Resolutions for a Healthy New You in the New Year
7. T.G.I. Fridays(R) Restaurants Releases 2008 Food-Related Resolutions Survey Results
8. If You Are 50 and Over, Make Getting Screened for Colorectal Cancer Your New Years Resolution
9. Sams Club Offers Health and Wellness Event Make New Year Resolutions Produce Real Results
10. YMCA of the USA Announces New Years Resolution to Better Support Health-Seeking Americans
11. A New Kind of New Years Resolution Could Bring Clarity to Americans

Post Your Comments:

[0] Soy Beneficial for Breast Cancer Survivors: Study [1] Researchers Use New Techniques to Assess PTSD [0] Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)[1] Patient Safety Organization (PSO) Participation: What Every Provider Needs to Know [1] Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)

Other Medicine News:Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 2 Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 3 Health News:Stigma Keeps Teens From Depression Treatment 2 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 2 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 3 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 4 Health News:Gyminee Raises 525K and Relaunches as DailyBurn 2 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 2 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 3 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 4 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 5 Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 2 Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 3

Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex Stigma Keeps Teens From Depression Treatment The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite Gyminee Raises 525K and Relaunches as DailyBurn Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking?Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making

Breaking Medicine Technology:Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 2 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 3 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 4 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 5 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 6 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 7 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 8 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 1 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 2 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 3 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 4 New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 1 New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 2 10 students receive scholarships for outstanding work in public health systems research 50092 1

[0] Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities [0] Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 [0] Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective

Other Medicine Technology:XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 2 XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 3 XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 4 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5

XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years

Medicine Products:

STA STACHROM PROTEIN C ASSERACHROM PROTEIN C STA ROTACHROM HEPARIN 4 STA DEFICIENT X

Resolution Health Introduces Women's Health and Wellness Actio...(mentById('headline'); s.tl(this'o'getLin...),Health